Corcept Therapeutics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Alaunos Therapeutics USD 845K 162K 2024-12
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Ardelyx USD 76.07M 11.1M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
J&J USD 5.11B 1.34B 2025-03
Knight Therapeutics CAD 25.48M 119K 2024-09
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
TG Therapeutics USD 38.96M 3M 2024-12



Corcept Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.